An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.
The therapy involves genetically programming cells from the patient’s own immune system to fight the disease.
The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22. All were severely ill, with acute lymphoblastic leukemia, and had relapsed several times or had never responded to typical therapies. In more than half, the disease had come back even after a stem-cell transplant, which usually gives patients the best hope of surviving. Their life expectancy was a few months, or in some cases just weeks.
Six months after being treated, 23 of the 30 patients were still alive, and 19 of them have remained in complete remission.
The study, by researchers at the Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania, is being published in The New England Journal of Medicine.
“We have a number of patients who are a year or more out and are in remission and not requiring other therapies,” said Dr. Stephan A. Grupp, who led the part of the study done at Children’s Hospital of Philadelphia. He said those long remissions gave the researchers hope that the treatment would have lasting effects.
Earlier reports by the same researchers involved only a handful of patients, some with chronic rather than acute leukemia. The scientists say the growing number of patients treated helps demonstrate that the findings are real.
The Latest on: Leukemia
[google_news title=”” keyword=”Leukemia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Leukemia
- ‘My faith is definitely my rock’: Jasper pitcher leans on faith through battle with Leukemiaon May 10, 2024 at 8:58 pm
My faith is definitely my rock, it keeps you anchored in hard times,” said Elise. And she stayed anchored, and determined. Determined to get back on the softball field. “There was no doubt she was ...
- Team Beachcomber rides PMC in honor of Calista Scribner as she valiantly fights leukemiaon May 10, 2024 at 8:00 am
On Saturday, April 27, 2024, 8-year-old Winchester cancer survivor and warrior Calista Scribner was honored at the 521 Overlook at Fenway Park. Scribner is a Jimmy Fund patient and Pan-Mass ...
- Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosison May 10, 2024 at 7:43 am
May 10 (Reuters) - A Pennsylvania jury ordered ExxonMobil (XOM.N) to pay $725.5 million to a former mechanic who claimed toxic chemicals in the company’s gasoline and solvents caused his cancer, ...
- Study: Older adults with aggressive blood cancer are responsive to treatment and show prolonged survivalon May 9, 2024 at 4:59 pm
Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this ...
- A New Kid on the Block of Therapy for Acute Myeloid Leukemiaon May 9, 2024 at 5:02 am
Crenolanib may have advantages over other therapies targeting acute myeloid leukemia with FLT3 gene mutations.
- Leukemia Relapse Could Be Prevented by Disrupting Immune Signaling Mechanismon May 8, 2024 at 6:13 pm
New study suggests that a subset of cancers with high levels of PI3KR5 expression might respond better to an experimental immunotherapy.
- Novel chemoimmunotherapy approach shows promise for B-cell acute lymphoblastic leukemia in phase 1 study at Fred Hutchon May 8, 2024 at 5:00 pm
In the first clinical trial of dose-adjusted EPOCH along with inotuzumab ozogamicin (InO) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), Fred Hutch Cancer Center ...
- New target for potential leukemia therapyon May 7, 2024 at 5:00 pm
The study provides both mechanistic and preclinical evidence supporting the rapid initiation of clinical trials for patients with acute myeloid leukemia (AML) to test an existing medicine that ...
- How Long Do You Have To Live With Leukemia? A Review By Doctorson May 7, 2024 at 2:28 pm
Expert opinion from Marcella Abunahman Pereira Specialization in Clinical Cardiology · 12 years of experience · Brazil Leukemia is a cancer that involves the white blood cells which are potent to ...
- Elise Lampert has leukemia. The Jasper pitcher refused to let it take away softballon May 2, 2024 at 8:05 am
She is choosing to remain positive. She is electing to stay active in the sport she loves. Lampert was diagnosed with chronic myeloid leukemia in December. It won’t be the end of her story. More: Here ...
via Bing News